Top Story

Study shows lifitegrast reduces dryness, discomfort

December 8, 2014

DENVER – Patients treated with lifitegrast showed improvement in symptoms but not signs of dry eye, according to a presenter here at the American Academy of Optometry meeting.

Paul M. Karpecki, OD, FAAO, presented results of OPUS-2, a phase 3 multicenter, randomized, double-masked, placebo-controlled trial of lifitegrast, an ICAM-1 decoy that targets chronic inflammation in dry eye disease.

Perspectives on Glaucoma

Meta-analysis shows latanoprost effective for angle-closure glaucoma

December 1, 2014
Researchers evaluated the results of 17 studies involving 807 patients and determined that latanoprost as monotherapy effectively reduced intraocular pressure in those…
Perspectives on Glaucoma

Corneal thickness monitoring recommended in patients on specific glaucoma therapies

November 28, 2014
Patients treated with prostaglandin monotherapy or a combined therapy of prostaglandins, carbonic anhydrase inhibitors and β-blockers should have regular central…
Meeting News Coverage

Drug eluting contact lenses 'worthy of investigation' for release of myopia drugs

November 26, 2014
DENVER – The combination of atropine and pirenzepine with commercial hydrogel and silicone hydrogel contact lenses may warrant further investigation, according to…
CME
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
thumbnail for video 3795241517001

Hom shares resources available for generic drugs

September 20, 2014
Milton Hom, OD, says the FDA has an online resource on generics and also discusses how older agents are now effective…
More »
Meeting News Coverage

Study shows lifitegrast reduces dryness, discomfort

December 8, 2014
DENVER – Patients treated with lifitegrast showed improvement in symptoms but not signs of dry eye, according to a presenter here at the…
Perspectives on Glaucoma

Meta-analysis shows latanoprost effective for angle-closure glaucoma

December 1, 2014
Researchers evaluated the results of 17 studies involving 807 patients and determined that latanoprost as monotherapy effectively reduced intraocular…
Perspectives on Glaucoma

Corneal thickness monitoring recommended in patients on specific glaucoma therapies

November 28, 2014
Patients treated with prostaglandin monotherapy or a combined therapy of prostaglandins, carbonic anhydrase inhibitors and β-blockers should…
Meeting News Coverage

Drug eluting contact lenses 'worthy of investigation' for release of myopia drugs

November 26, 2014
DENVER – The combination of atropine and pirenzepine with commercial hydrogel and silicone hydrogel contact lenses may warrant further…
Prakash Nagarkatti, PhD Meeting News Coverage

Speakers share latest research on cannabinoids

November 18, 2014
DENVER – Three presenters here at the American Academy of Optometry plenary session discussed the dangers of recreational use of cannabinoids…
thumbnail for video 3893060986001 Meeting News CoverageVideo

Experienced ODs prescribe more branded products

November 15, 2014
Agustin Gonzalez, OD, discusses two posters he presented here at the American Academy of Optometry meeting on the prescribing habits of optometrists…

Allergic conjunctivitis treatment market: Slow growth, patent expirations

November 3, 2014
The research and consulting firm GlobalData’s report on the allergic conjunctivitis treatment market shows minimal growth from $1.37 billion in…

PCON to sponsor academy plenary on cannabinoids

October 8, 2014
The plenary session at this year’s American Academy of Optometry annual meeting will explore the health benefits and risks of cannabinoids…
thumbnail for video 3795241517001 Meeting News CoverageVideo

Hom shares resources available for generic drugs

September 20, 2014
Milton Hom, OD, says the FDA has an online resource on generics and also discusses how older agents are now effective against new…
FDA News

Herantis Pharma pursues phase 2 study for dry eye treatment

September 15, 2014
The U.S. Food and Drug Administration has cleared the Investigational New Drug application of Herantis Pharma for a phase 2 clinical study of Cis-UCA…
More Headlines »
morganatic-roan